The Steering Committee of the former ISPE UK Affiliate PAT CoP are pleased to announce a transition from functioning under the ISPE banner, to working under the CPACT banner, under the name ‘Pharmaceutical PAT Community of Practice’. The current steering committee includes representation from AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, MWC Ltd, Organon and Pfizer.
The purpose of the PAT CoP is to bring together a diverse group of people from pharmaceutical companies, analytical instruments and software suppliers, academia and regulators with an interest in the applications of PAT in development and manufacturing of pharmaceutical products. We have approximately 70 members, with representation from large and small pharma and biopharma, CRO and CMOs, academia, suppliers of analytical instrumentation, suppliers of software solutions and consultants.
The main scope of the CoP is to share example applications in an informal setting, network with colleagues that are practitioners in this area, and develop guidance on selected topics that benefit the group and the wider community. Key activities include sharing applications of PAT at CoP meetings, awareness of regulatory guidance, discussion of new developments in the area in an informal setting, and participation in workgroups focussing on specific topics to prepare guidance to benefit the PAT Community. The current workgroup topic is building an online PAT unit operations capability map, with the vision to produce a simple tool that can be used across the industry allowing PAT practitioners to both find and update the relevant information quickly.
We encourage both existing and new members to join the Pharmaceutical PAT Community of Practice – it is free to join, and independent of individual/company CPACT membership status. Members will have access to the Pharmaceutical PAT Community of Practice webspace on the CPACT website, and all CoP events and activities.
Further details can be found at:
Joining instructions
If you wish to become a member of the PAT CoP, then you should create a new account using your own individual company/personal email address when you click here:
Members of CPACT
If you are already a member of CPACT, you can access the PAT CoP section via the 'members only' section of the CPACT website using your company login details. This will allow you to access the capability map.
Upcoming CoP events – Save the dates:
Please join us for our virtual kick-off meeting to find out more about the Pharmaceutical PAT Community of Practice: 29th April 2022, 14:00-16:00 (UK time).
We are also giving advanced notice of the annual face to face meeting, due to be held at the new Medicine Manufacturing Innovation Centre (www.uk-cpi.com/mmic ) on the 13th October 2022. This will include a tour of the facility and a chance to view the on-going Grand Challenges such as GC1 (Continuous Direct Compression Digital Test-Bed) and GC2 (PACE, Automated Clinical Trial Packing and QP Release Platform). More details to follow.
Pharmaceutical PAT CoP Steering Committee
Matthew Cannon (GlaxoSmithKline), Lucy Hawarden (Chair, Bristol-Myers Squibb), James MacGregor (Pfizer), Juan Rosas (Organon), Kevin Sutcliffe (AstraZeneca), Martin Warman (MWC Ltd)